Publication | Open Access
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study
20
Citations
22
References
2020
Year
ClinicalTrials.gov, NCT02959177 (registered November 7, 2016).
| Year | Citations | |
|---|---|---|
Page 1
Page 1